Vaccine type
- Inactivated water-based vaccine for intramuscular and intraperitoneal injections
Target Diseases
- Iridoviral disease caused by infectious spleen and kidney necrosis virus (ISKNV)
- Streptococcosis caused by Streptococcus iniae
Target Species
- Asian seabass or barramundi
Key Features
- Rapid protection within 3 dpv against ISKNV and S. iniae in Asian seabass
- Long duration of protection against iridoviral disease and streptococcosis for at least 2 mpv and 11 mpv, respectively
Efficacy
Laboratory test Trial I
Pathogens
|
DPV |
RPS |
ISKNV
|
21 |
76 |
S. iniae
|
32 |
78 |
Laboratory test Trial II
Pathogens
|
DPV |
RPS |
ISKNV
|
3 |
89 |
7 |
85 |
14 |
79 |
S. iniae
|
3 |
89 |
7 |
97 |
14 |
100 |
Laboratory test Trial III
Pathogens
|
DPV |
RPS |
ISKNV
|
28 |
90 |
74 |
75 |
S. iniae
|
102 |
90 |
348 |
88 |
DPV: days post-vaccination
RPS: relative percent survival